TSE:MFC

Manulife Financial (MFC.TO)

57.19
+0.15 (0.26%)
as of Jun 26, 2026, 8:00:00 pm Market Open.
1634 watching
0
Investor Insights
star iconJun 27, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from experts, highlighting its strengths in capital management, particularly in Asia and wealth management. Several analysts view it as a reliable income stock, benefiting from a decent dividend yield, yet caution against its growth potential compared to Canadian banks. The company has faced short-term challenges, including mixed results from its alternative portfolio and limited growth in its U.S. operations, which has sparked some concerns. Analysts suggest waiting for opportunities to buy during pullbacks, given its valuation relative to major financials, alongside the potential for increased profitability stemming from rising interest rates. Overall, while MFC is generally recognized for its stability and improvements in earnings quality, it struggles to capture investor attention amidst recent market shifts.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
SLF-T
BUY ON WEAKNESS

This is a name that is just going to go higher. It is still under-owned in people’s portfolios. Rising yields and rising equity markets are going to be a wind at their back. Getting into new businesses and he expected them to have new business strain costs as a result, but those costs have been lower than expected. Sees it as an upside in Asia and the US.

BUY ON WEAKNESS

Thinks the stock goes higher and expects we will see a dividend increase at the end of this year or into January. However, the stock is getting up there. Thinks the quarter coming out next week will be flattish and might take $0.50 off of the stock. It is more of a Buy in the $17 area. 2.8% dividend yield.

COMMENT

Had a nice run recently and he thinks this will continue. This is partially to do with realization that post earlier returns can get better if you have a little bit of interest-rate movement and no other problems. He can see it gradually continuing up.

BUY

You are in the sweet spot with all financials. With this one he has a coming out of the blue strategy. This one came out of the blue some time ago. He would still buy it or hold it. Model $20.04. Yield of 2.9%.

WATCH

Lifecos have had a good run because of the interest-rate rises. It is now approaching the resistance level of about $19-$20 and his concern is that a lot of patient investors will be selling their holdings once it gets close to that level, it will be hard to break through that resistance. Watch to see if it can break through that level and if it can, that is a very positive sign. If it gets turned down, it will have more trouble breaking through. Seasonally, lifecos have a similar seasonality to banks but, when interest rates are changing the way they are, it can have a different impact.

BUY ON WEAKNESS

Insurers have had a big run in the last little while and even in the near-term. This one is showing a pretty high relative strength index, so it is quite overbought at this point. He would prefer it at $16-$16.50 level. Likes Sun Life (SLF-T) a little bit more whose dividend is a little bit greater.

HOLD

Coming into some old levels of resistance (2011) but basically the trend has been good. The chart shows a classic break of resistance at $14-$14.50 area. It broke and then it tested. Stock looks good but is probably a little ahead of itself right now and it probably needs to pull back to the trend line. If you don’t own, he would wait for a little bit of a pull back.

BUY

Unfortunately, stock has had a very nice move over the last 3 or 4 months. Still doesn’t think it is too late. One of the reasons it has come back is because of increased interest rates. On the equity side, they have been able to take some advantage on the rising market in getting their equity portfolios back up but have also taken the opportunity to hedge some.

WEAK BUY

This is one of the beneficiaries of higher interest rates. The valuation of the liability pool gets less as interest rates go up. It is not as risk-free as you think. They were exposed to the equity market but took some of that off the table to survive. It is a stock to be in when everyone thinks interest rates are going up. Prefers SLF-T

PAST TOP PICK

(Top Pick Sep 11/12, Up 47.71%) They hedged a lot of their problems with the markets. One can see earnings getting back and going higher over time. He has to buy things when they are cheap and out of favour as long as he thinks they will come back.

BUY

Coming out of the blue in his blog $18.18 model price. As interest rates move higher they will do quite well.

DON'T BUY

Biggest beneficiary of rising interest rates. Next 6-12 months he doesn’t think interest rates will normalize, but if they did it would be a good buy. Don’t chance insurance companies here.

DON'T BUY

Was stunned to see a report that there is a huge increase in short interest. Maybe US hedge funds are doing the same thing as they did to banks. He likes conservative banks.

HOLD

He is more interested in TD because of 10 times earnings vs. 12 times earnings with MFC-T.

BUY

Any time this company can issue an earnings report that is not convoluted with all kinds of footnotes, you have to like it. Came out very clean last quarter. Companies like this will do very well in a rising interest rate and rising stock market environment. Pays a great yield.

Showing 1,126 to 1,140 of 2,281 entries